ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The Danish drugmaker Lundbeck has appointed Deborah Dunsire, former head of several U.S. firms, including Millennium Pharmaceuticals, as its new CEO. Lundbeck cites Dunsire’s management and research experience as well as her “robust knowledge and experience in neuroscience” as key qualifications. Dunsire, a medical doctor from South Africa, has worked in the U.S. since 1994 and will now move to Denmark. Lundbeck has had an interim CEO since 2017, when Kåre Schultz left to head Teva Pharmaceutical.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X